AI could save lives after emergency heart surgery
NCT ID NCT07623213
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an artificial intelligence (AI) program can improve follow-up care for people who had emergency surgery for a torn aorta (aortic dissection). About 1,314 adults will be randomly assigned to either standard follow-up or AI-guided follow-up, where the AI predicts risk and prompts extra check-ups for high-risk patients. The main goal is to see if the AI approach lowers the chance of death within one year after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AI prediction model-guided intensified follow-up strategy
- What this could lead to
- If successful, this could show that AI-driven follow-up reduces deaths and complications after aortic dissection surgery, leading to better long-term care.
- What could go wrong
- This trial is not yet recruiting and is early-stage. The AI model may not improve outcomes over standard care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,314 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Age 18 years or older. 2. Acute Stanford type A aortic dissection confirmed by CTA, intraoperative findings, or medical records. 3\. Underwent open surgical repair or open repair combined with endovascular/hybrid repair. 4\. Postoperative condition is stable and the patient is planned for discharge or has entered early post-discharge follow-up. 5\. Core baseline data required for AI model operation are available, including at least one eligible preoperative or postoperative CTA imaging dataset. 6\. Able to complete telephone, outpatient, or inpatient follow-up and willing to provide written informed consent. Exclusion Criteria: * 1\. Predominantly chronic type A dissection, traumatic dissection, or iatrogenic dissection, if the investigator judges the patient unsuitable for this follow-up strategy study. 2\. Did not undergo surgical repair, received only palliative treatment, or did not meet postoperative randomization conditions. 3\. Expected inability to complete 12-month follow-up, no stable contact information, or inability to obtain outpatient, telephone, or inpatient follow-up data. 4\. Severe missing baseline data preventing generation of the AI risk report. 5. Concurrent participation in another interventional study that may substantially affect postoperative follow-up intensity or the primary outcome. 6\. Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute type A aortic dissection are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.